Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory Large B-cell Lymphoma (LBCL)

Clinical trial condition

Relapsed/Refractory Large B-cell Lymphoma (LBCL)

Explore clinical trials studying Relapsed/Refractory Large B-cell Lymphoma (LBCL). Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed/Refractory Large B-cell Lymphoma (LBCL) trial results

Recruiting

A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7×19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma

NCT07788118

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Disease Attributes, Hemic and Lymphatic Diseases, +18 more
Locations: The Second Affiliated Hospital,School of Medicine,Zhejiang University, Hangzhou, Zhejiang 310009 Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL

NCT07613788

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China

View Trial Details